Brooklyn Stock Alpha and Beta Analysis

BTX -  USA Stock  

USD 0.57  0.03  5.00%

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Brooklyn Immunotherapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Brooklyn Immunotherapeuti over a specified time horizon. Remember, high Brooklyn Immunotherapeuti's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Continue to Brooklyn Immunotherapeuti Backtesting, Brooklyn Immunotherapeuti Valuation, Brooklyn Immunotherapeuti Correlation, Brooklyn Immunotherapeuti Hype Analysis, Brooklyn Immunotherapeuti Volatility, Brooklyn Immunotherapeuti History and analyze Brooklyn Immunotherapeuti Performance.
Please note that although Brooklyn Immunotherapeuti alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Brooklyn Immunotherapeuti did 1.54  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Brooklyn Immunotherapeutics stock's relative risk over its benchmark. Brooklyn Immunotherapeuti has a beta of 1.80  . Let's try to break down what Brooklyn's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Brooklyn Immunotherapeuti will likely underperform.
Brooklyn Immunotherapeuti Price to Book Value is fairly stable at the moment as compared to the past year. Brooklyn Immunotherapeuti reported Price to Book Value of 33.38 in 2021. Tangible Assets Book Value per Share is likely to rise to 0.72 in 2022, whereas Enterprise Value over EBIT is likely to drop (2.36)  in 2022.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Brooklyn Immunotherapeuti Quarterly Book Value per Share



Brooklyn Immunotherapeuti Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Brooklyn Immunotherapeuti market risk premium is the additional return an investor will receive from holding Brooklyn Immunotherapeuti long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Brooklyn Immunotherapeuti. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Brooklyn Immunotherapeuti's performance over market.
α-1.54   β1.80
90 days against DJI

Brooklyn Immunotherapeuti expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Brooklyn Immunotherapeuti's Buy-and-hold return. Our buy-and-hold chart shows how Brooklyn Immunotherapeuti performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Brooklyn Immunotherapeuti Market Price Analysis

Market price analysis indicators help investors to evaluate how Brooklyn Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Brooklyn Immunotherapeuti shares will generate the highest return on investment. By understating and applying Brooklyn Immunotherapeuti stock market price indicators, traders can identify Brooklyn Immunotherapeuti position entry and exit signals to maximize returns.

Brooklyn Immunotherapeuti Return and Market Media

The median price of Brooklyn Immunotherapeuti for the period between Sat, Mar 26, 2022 and Fri, Jun 24, 2022 is 0.93 with a coefficient of variation of 49.95. The daily time series for the period is distributed with a sample standard deviation of 0.56, arithmetic mean of 1.12, and mean deviation of 0.48. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
EPS Estimate03/31/2022
EPS Reported04/12/2022
Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Ful...04/14/2022
Financial Statements04/19/2022
Brooklyn ImmunoTherapeutics Announces Establishment of New R...04/21/2022
Brooklyn ImmunoTherapeutics Announces Receipt of Notice from...05/27/2022
Financial Statements05/31/2022
Brooklyn Immunotherapeuti exotic insider transaction detecte...06/01/2022
Acquisition by Jackson Andrew C of 664800 shares of Brooklyn...06/06/2022
Brooklyn Immunotherapeuti exotic insider transaction detecte...06/07/2022
Brooklyn ImmunoTherapeutics receives non-compliance letter f...06/17/2022
EPS Reported06/21/2022

About Brooklyn Immunotherapeuti Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Brooklyn Immunotherapeuti has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2019 2020 2021 2022 (projected)
Receivables Turnover3.6511.3510.2111.02
PPandE Turnover0.850.871.01.03

Brooklyn Immunotherapeuti Upcoming Company Events

As portrayed in its financial statements, the presentation of Brooklyn Immunotherapeuti's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brooklyn Immunotherapeuti's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Brooklyn Immunotherapeuti's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Brooklyn Immunotherapeuti. Please utilize our Beneish M Score to check the likelihood of Brooklyn Immunotherapeuti's management manipulating its earnings.
Upcoming Quarterly Report10th of March 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End10th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Brooklyn Immunotherapeuti

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Continue to Brooklyn Immunotherapeuti Backtesting, Brooklyn Immunotherapeuti Valuation, Brooklyn Immunotherapeuti Correlation, Brooklyn Immunotherapeuti Hype Analysis, Brooklyn Immunotherapeuti Volatility, Brooklyn Immunotherapeuti History and analyze Brooklyn Immunotherapeuti Performance. Note that the Brooklyn Immunotherapeuti information on this page should be used as a complementary analysis to other Brooklyn Immunotherapeuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Brooklyn Stock analysis

When running Brooklyn Immunotherapeuti price analysis, check to measure Brooklyn Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn Immunotherapeuti is operating at the current time. Most of Brooklyn Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn Immunotherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn Immunotherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Brooklyn Immunotherapeuti technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Brooklyn Immunotherapeuti technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Brooklyn Immunotherapeuti trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...